I-BiT - Evaluation of a Novel Binocular Treatment System (I-BiTTM) in Children With Amblyopia
Launched by NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST · Oct 5, 2012
Trial Information
Current as of May 09, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion criteria:
- • Diagnosis of Anisometropic, Strabismic or Mixed Amblyopia as made by an Orthoptist
- • Male or Female
- • Aged 4 - 8 years inclusive.
- • Participant's parent or guardian is willing and able to give informed consent for participation in the study
- Exclusion criteria:
- • Stimulus deprivation amblyopia.
- • Organic lesions of the eye preventing the establishment of good vision (e.g. media opacities, abnormalities in the fundus or optic nerve).
- • Lesions of the brain preventing the establishment of good vision (e.g. cortical visual impairment).
- • Patients diagnosed with Photosensitive Epilepsy
- • Patients diagnosed with or suspected of having Conjunctivitis
- • Loss of suppression at filter 4 or less as measured with the Sbisa Bar
- • Establishment of normal vision by refractive adaptation (wearing glasses after presentation).
- • Inability to comply with the follow up visits required
- • Refusal to accept randomisation
- • Have participated in a previous study examining I-BiT treatment
About Nottingham University Hospitals Nhs Trust
Nottingham University Hospitals NHS Trust is a leading healthcare provider in the UK, dedicated to delivering high-quality patient care and advancing medical research. Comprising two major hospitals, Queen's Medical Centre and Nottingham City Hospital, the Trust is at the forefront of clinical innovation and education. With a strong emphasis on translational research, Nottingham University Hospitals NHS Trust actively sponsors clinical trials aimed at improving treatment outcomes and understanding various health conditions. The Trust collaborates with academic institutions, healthcare professionals, and industry partners to foster a robust research environment that enhances clinical practice and contributes to evidence-based medicine.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Nottingham, , United Kingdom
Cambridge, Cambridgeshire, United Kingdom
Patients applied
Trial Officials
Alexander Foss, BA BMBCh MRCP MRCOphth FRC
Principal Investigator
Consultant Ophthalmologist
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials